118 related articles for article (PubMed ID: 15917878)
1. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
[TBL] [Abstract][Full Text] [Related]
2. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
[TBL] [Abstract][Full Text] [Related]
6. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
Eur Heart J; 2002 May; 23(9):726-33. PubMed ID: 11977999
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty.
Li XP; Zhou SH; Tang JJ; Liu QM; Fang ZF; Hu XQ; Zhou T; Sheng XQ; Zhao SP
Circ J; 2008 May; 72(5):729-33. PubMed ID: 18441451
[TBL] [Abstract][Full Text] [Related]
9. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
[TBL] [Abstract][Full Text] [Related]
10. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
[TBL] [Abstract][Full Text] [Related]
11. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
[TBL] [Abstract][Full Text] [Related]
12. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
Breuckmann F; Naber C; Beckert J; Schmermund A; Haude M; Baumgart D; Erbel R
Int J Cardiol; 2006 Mar; 108(1):20-5. PubMed ID: 16516694
[TBL] [Abstract][Full Text] [Related]
13. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris.
Zouridakis E; Avanzas P; Arroyo-Espliguero R; Fredericks S; Kaski JC
Circulation; 2004 Sep; 110(13):1747-53. PubMed ID: 15381646
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.
Wong CK; Hammett CJ; The R; French JK; Gao W; Webber BJ; Elliott JM; Hamer AW; Ormiston JA; Webster MW; Stewart RA; Ameratunga RV; White HD
Heart; 2004 Nov; 90(11):1299-302. PubMed ID: 15486126
[TBL] [Abstract][Full Text] [Related]
15. The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention.
Yan JC; Ma GS; Zhu J; Feng Y; Luo D; Wu ZG; KingG XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2006 Dec; 374(1-2):140-1. PubMed ID: 16820144
[No Abstract] [Full Text] [Related]
16. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
Hausleiter J; Kastrati A; Mehilli J; Vogeser M; Zohlnhöfer D; Schühlen H; Goos C; Pache J; Dotzer F; Pogatsa-Murray G; Dirschinger J; Heemann U; Schömig A;
Circulation; 2004 Aug; 110(7):790-5. PubMed ID: 15302787
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention.
McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
Clin Cardiol; 2010 Nov; 33(11):678-85. PubMed ID: 21089112
[TBL] [Abstract][Full Text] [Related]
19. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.
Yan JC; Ding S; Liang Y; Ma GS; Zhu J; Feng Y; Luo D
Acta Pharmacol Sin; 2007 Mar; 28(3):339-43. PubMed ID: 17302995
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
Bestehorn HP; Neumann FJ; Büttner HJ; Betz P; Stürzenhofecker P; von Hodenberg E; Verdun A; Levai L; Monassier JP; Roskamm H
J Am Coll Cardiol; 2004 Jun; 43(12):2160-5. PubMed ID: 15193674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
